✦ LIBER ✦

Trastuzumab (Herceptin®) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients

✍ Scribed by Marc Salzberg; Markus Borner; Jean-Alexandre Bauer; Rudolf Morant; Daniel Rauch; Christoph Rochlitz

Book ID: 116429088
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 84 KB
Volume: 42
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2006.06.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab (Herceptin™) in Metastatic T

Trastuzumab (Herceptin™) in Metastatic Transitional Cell Carcinoma of the Urinary Tract: Report on Six Patients

✍ Michaël Peyromaure; Florian Scotté; Delphine Amsellem-Ouazana; Annick Vieillefon 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Results of a phase II study of liposomal

Results of a phase II study of liposomal doxorubicin (Myocet®) in combination with weekly paclitaxel and trastuzumab (Herceptin®) In patients with HER2-positive locally advanced or metastatic breast cancer (LA/MBC)

✍ J Baselga; M.A Climent; A Lluch; J Hornedo; P Gascon; A.T Sanchez; V Guillem; H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 173 KB

A single-arm, multicenter, open-label ph

A single-arm, multicenter, open-label phase 2 study of lapatinib as the second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma

✍ Christian Wülfing; Jean-Pascal H. Machiels; Dirk J. Richel; Marc-Oliver Grimm; U 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

Long-Term Survival after Gemcitabine and

Long-Term Survival after Gemcitabine and Cisplatin in Patients with Locally Advanced Transitional Cell Carcinoma of the Bladder: Focus on Supplementary Treatment Strategies

✍ Anne Birgitte Als; Lisa Sengelov; Hans von der Maase 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Re: Final results of sequential doxorubi

Re: Final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium

✍ Christopher J. Logothetis; Arlene Siefker-Radtke 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Editorial Comment on: Long-Term Survival

Editorial Comment on: Long-Term Survival after Gemcitabine and Cisplatin in Patients with Locally Advanced Transitional Cell Carcinoma of the Bladder: Focus on Supplementary Treatment Strategies

✍ Juergen E. Gschwend 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB